Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Sumitomo Dainippon Pharma launches TWYMEEG in Japan
Sumitomo Dainippon Pharma launched TWYMEEG 500mg tablets for type 2 diabetes in Japan on September 16. Poxel is entitled to royalties and sales-based payments under its license agreement.
2019
Myovant closes increased $400 million loan facility
Myovant Sciences announced the closing of its loan facility from Sumitomo Dainippon Pharma, increased to $400 million; the company said it would use the increased facility to repay its existing loans.